Dario Roccatello Selected Research

Glycoproteins (Glycoprotein)

10/2020	Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome.
7/2018	Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review.
1/2018	Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.
9/2017	Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.
1/2015	The global anti-phospholipid syndrome score in primary APS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dario Roccatello Research Topics

Disease

28	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2022 - 12/2011
20	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022 - 05/2002
19	Vasculitis (Vasculitides) 03/2022 - 07/2008
17	Proteinuria 01/2022 - 01/2007
16	Infections 01/2022 - 12/2004
14	Glomerulonephritis 01/2022 - 12/2004
12	Thrombosis (Thrombus) 05/2021 - 08/2012
8	Cryoglobulinemia 01/2022 - 01/2007
8	Rheumatoid Arthritis 01/2022 - 01/2009
8	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 05/2014
8	Hypertension (High Blood Pressure) 01/2018 - 09/2004
7	Lupus Nephritis 05/2022 - 01/2013
7	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 05/2002
6	Inflammation (Inflammations) 03/2022 - 01/2009
6	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 09/2011
6	Renal Insufficiency (Renal Failure) 01/2022 - 01/2007
6	Nephritis 03/2020 - 07/2008
5	COVID-19 01/2022 - 05/2020
5	Systemic Vasculitis 09/2011 - 12/2004
4	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022 - 01/2013
4	Fibrosis (Cirrhosis) 11/2021 - 08/2016
4	Chronic Renal Insufficiency 01/2021 - 01/2013
4	Immunoglobulin Light-chain Amyloidosis 01/2021 - 06/2020
4	Venous Thrombosis (Deep-Vein Thrombosis) 12/2020 - 09/2015
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2015 - 05/2002
3	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022 - 01/2011
3	Arthritis (Polyarthritis) 12/2021 - 12/2011
3	Giant Cell Arteritis (Horton Disease) 03/2021 - 09/2011
3	Neoplasms (Cancer) 01/2021 - 03/2016
3	Immunoglobulin G4-Related Disease 12/2020 - 08/2016
3	Interstitial Nephritis (Tubulointerstitial Nephritis) 12/2020 - 08/2016
3	Paraproteinemias (Monoclonal Gammopathy) 09/2020 - 01/2019
3	Peripheral Nervous System Diseases (PNS Diseases) 06/2011 - 09/2004
2	Amyloidosis 01/2022 - 01/2021
2	Wounds and Injuries (Trauma) 01/2022 - 08/2020
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 06/2018
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 01/2014
2	Thrombocytopenia (Thrombopenia) 01/2021 - 02/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 02/2017
2	Ulcer 01/2021 - 02/2008
2	Retroperitoneal Fibrosis 12/2020 - 04/2018
2	Rheumatic Diseases (Rheumatism) 12/2020 - 10/2017
2	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2019 - 06/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 09/2016
2	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2018 - 01/2017
2	Microscopic Polyangiitis 08/2017 - 01/2011
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 08/2017 - 01/2011
2	Obesity 02/2017 - 06/2012
2	Connective Tissue Diseases (Connective Tissue Disease) 03/2016 - 01/2009

Drug/Important Bio-Agent (IBA)

28	Rituximab (Mabthera)FDA Link 01/2022 - 12/2004
23	Antiphospholipid AntibodiesIBA 09/2022 - 08/2012
19	AntibodiesIBA 01/2022 - 02/2014
12	CreatinineIBA 01/2022 - 01/2007
11	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2022 - 01/2009
9	SteroidsIBA 01/2021 - 01/2011
8	Monoclonal AntibodiesIBA 01/2022 - 12/2004
8	Immunoglobulin G (IgG)IBA 04/2021 - 09/2004
6	Immunoglobulin M (IgM)IBA 04/2021 - 02/2008
6	Prothrombin (Factor II)IBA 01/2021 - 02/2014
5	Complement System Proteins (Complement)IBA 03/2022 - 01/2019
5	Prednisone (Sone)FDA LinkGeneric 01/2022 - 03/2012
5	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2017
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2012
5	AutoantibodiesIBA 04/2021 - 02/2014
5	Biological ProductsIBA 03/2021 - 06/2013
5	PhosphatidylserinesIBA 01/2021 - 02/2014
5	Glycoproteins (Glycoprotein)IBA 10/2020 - 01/2015
5	Immunosuppressive Agents (Immunosuppressants)IBA 05/2018 - 09/2012
4	TinIBA 01/2022 - 08/2016
4	Antiviral Agents (Antivirals)IBA 11/2021 - 09/2012
4	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2020 - 09/2014
4	Immunoglobulin A (IgA)IBA 03/2020 - 03/2005
4	CD20 AntigensIBA 06/2013 - 12/2004
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 04/2020
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
3	Methylprednisolone FDA LinkGeneric 01/2022 - 12/2011
3	GlucocorticoidsIBA 06/2021 - 06/2012
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020 - 01/2016
3	Vitamin K FDA Link 11/2018 - 10/2016
3	C-Reactive ProteinIBA 01/2018 - 01/2011
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2012 - 03/2008
2	Prealbumin (Transthyretin)IBA 01/2022 - 01/2022
2	tofacitinibIBA 01/2022 - 01/2020
2	tocilizumab (atlizumab)FDA Link 03/2021 - 05/2020
2	anti-dsDNA autoantibodyIBA 01/2021 - 12/2015
2	CytokinesIBA 12/2020 - 04/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 12/2017
2	daratumumabIBA 10/2020 - 09/2020
2	Anticardiolipin AntibodiesIBA 10/2020 - 09/2017
2	Azathioprine (Imuran)FDA LinkGeneric 05/2018 - 01/2013
2	LipidsIBA 01/2018 - 01/2015
2	AnticoagulantsIBA 12/2017 - 10/2016
2	Thrombin FDA Link 09/2016 - 01/2016

Therapy/Procedure

42	Therapeutics 01/2022 - 10/2003
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
3	Off-Label Use 05/2020 - 09/2011
3	Biological Therapy 02/2017 - 08/2015
2	Immunotherapy 01/2018 - 01/2017
2	Radiotherapy 01/2017 - 03/2016